Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology.

Abstract

NTX is FDA-approved for opiate and alcohol use disorders as anti-craving agent. It has been used successfully off-label in other psychiatric indications. Here, we shed some light on these while examining the extant evidence.